Tekla Capital Management LLC
- SEC CIK
- 0001300336
- Latest filing
- Aug 10, 2023
Holdings in Q4 2022
Holdings as of Dec 31, 2022, filed Feb 10, 2023. Long positions only; changes compare share counts with Q3 2022.
- Positions
- 172
- +4 vs. Q3 2022
- Portfolio value
- $2.65B
- +$205.2M (+8.4%) vs. Q3 2022
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| UNHUnitedHealth Group Inc | Stock | 270,546 | $143.4M | 5.4% | −3,500−1.3% | Reduced | History |
| AMGNAmgen Inc | Stock | 508,676 | $133.6M | 5.0% | −10,193−2.0% | Reduced | History |
| GILDGilead Sciences, Inc. | Stock | 1,510,440 | $129.7M | 4.9% | −111,725−6.9% | Reduced | History |
| JNJJohnson & Johnson | Stock | 639,679 | $113.0M | 4.3% | −144,100−18.4% | Reduced | History |
| LLYEli Lilly & Co | Stock | 288,917 | $105.7M | 4.0% | +48,339+20.1% | Added | History |
| VRTXVertex Pharmaceuticals Inc | Stock | 330,343 | $95.4M | 3.6% | +16,940+5.4% | Added | History |
| REGNRegeneron Pharmaceuticals, Inc. | COM | 120,862 | $87.2M | 3.3% | +11,800+10.8% | Added | History |
| ABBVAbbVie Inc. | Stock | 478,342 | $77.3M | 2.9% | −48,500−9.2% | Reduced | History |
| ABTAbbott Laboratories | Stock | 693,051 | $76.1M | 2.9% | −98,000−12.4% | Reduced | History |
| PFEPfizer Inc | Stock | 1,457,170 | $74.7M | 2.8% | +325,067+28.7% | Added | History |
| AZNAstraZeneca PLC | SPONSORED ADR | 1,022,255 | $69.3M | 2.6% | −250,938−19.7% | Reduced | History |
| ILMNIllumina, Inc. | COM | 319,958 | $64.7M | 2.4% | +25,015+8.5% | Added | History |
| MRKMerck & Co., Inc. | Stock | 552,122 | $61.3M | 2.3% | 00.0% | Unchanged | History |
| CICigna Group | Stock | 182,631 | $60.5M | 2.3% | −28,100−13.3% | Reduced | History |
| BIIBBiogen Inc. | COM | 195,430 | $54.1M | 2.0% | +49,991+34.4% | Added | History |
| TMOThermo Fisher Scientific Inc. | Stock | 93,705 | $51.6M | 1.9% | 00.0% | Unchanged | History |
| BMYBristol Myers Squibb Co | Stock | 687,529 | $49.5M | 1.9% | −191,947−21.8% | Reduced | History |
| MRNAModerna, Inc. | Stock | 264,927 | $47.6M | 1.8% | −49,997−15.9% | Reduced | History |
| HZNPHorizon Therapeutics Public Ltd Co | SHS | 415,053 | $47.2M | 1.8% | −319,300−43.5% | Reduced | History |
| SYKStryker Corp | Stock | 164,128 | $40.1M | 1.5% | −29,400−15.2% | Reduced | History |
| HUMHumana Inc | Stock | 77,713 | $39.8M | 1.5% | −35,291−31.2% | Reduced | History |
| BSXBoston Scientific Corp | Stock | 757,015 | $35.0M | 1.3% | −38,200−4.8% | Reduced | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 143,214 | $34.0M | 1.3% | 00.0% | Unchanged | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 258,868 | $33.0M | 1.2% | 00.0% | Unchanged | History |
| UTHRUnited Therapeutics Corp | COM | 115,077 | $32.0M | 1.2% | −2,300−2.0% | Reduced | History |
| ARGXArgenx SE | SPONSORED ADR | 84,021 | $31.8M | 1.2% | +7,386+9.6% | Added | History |
| ISRGIntuitive Surgical Inc | COM NEW | 112,680 | $29.9M | 1.1% | +8,277+7.9% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 182,782 | $29.1M | 1.1% | 00.0% | Unchanged | History |
| DHRDanaher Corp | Stock | 105,690 | $28.1M | 1.1% | −18,866−15.1% | Reduced | History |
| IDXXIDEXX Laboratories Inc | COM | 68,065 | $27.8M | 1.0% | +13,858+25.6% | Added | History |
| MDTMedtronic plc | Stock | 326,172 | $25.4M | 1.0% | 00.0% | Unchanged | History |
| HCAHCA Healthcare, Inc. | COM | 105,003 | $25.2M | 1.0% | −19,300−15.5% | Reduced | History |
| MCKMcKesson Corp | Stock | 66,455 | $24.9M | 0.9% | +32,798+97.4% | Added | History |
| DXCMDexcom Inc | COM | 218,015 | $24.7M | 0.9% | −27,697−11.3% | Reduced | History |
| MOHMolina Healthcare, Inc. | COM | 73,615 | $24.3M | 0.9% | −45,920−38.4% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 230,790 | $23.9M | 0.9% | +79,843+52.9% | Added | History |
| ZTSZoetis Inc. | Stock | 136,914 | $20.1M | 0.8% | 00.0% | Unchanged | History |
| SRPTSarepta Therapeutics, Inc. | COM | 140,959 | $18.3M | 0.7% | −25,000−15.1% | Reduced | History |
| NVONovo Nordisk A S | ADR | 130,523 | $17.7M | 0.7% | 00.0% | Unchanged | History |
| LNTHLantheus Holdings, Inc. | Stock | 342,872 | $17.5M | 0.7% | +113,693+49.6% | Added | History |
| CRLCharles River Laboratories International, Inc. | COM | 72,675 | $15.8M | 0.6% | 00.0% | Unchanged | History |
| BNTXBioNTech SE | SPONSORED ADS | 103,858 | $15.6M | 0.6% | +8,816+9.3% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 123,791 | $15.1M | 0.6% | +55,997+82.6% | Added | History |
| QUREuniQure N.V. | SHS | 652,446 | $14.8M | 0.6% | +130,753+25.1% | Added | History |
| SGENSeagen Inc. | COM | 112,214 | $14.4M | 0.5% | +58,827+110.2% | Added | History |
| NBIXNeurocrine Biosciences Inc | Stock | 112,908 | $13.5M | 0.5% | −55,200−32.8% | Reduced | History |
| IQVIQVIA Holdings Inc. | Stock | 63,117 | $12.9M | 0.5% | −4,700−6.9% | Reduced | History |
| GHGuardant Health, Inc. | COM | 472,184 | $12.8M | 0.5% | +126,100+36.4% | Added | History |
| EWEdwards Lifesciences Corp | Stock | 171,388 | $12.8M | 0.5% | 00.0% | Unchanged | History |
| RMDResmed Inc | COM | 60,699 | $12.6M | 0.5% | 00.0% | Unchanged | History |
| NVSNovartis AG | ADR | 136,225 | $12.4M | 0.5% | 00.0% | Unchanged | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 147,677 | $12.3M | 0.5% | 00.0% | Unchanged | – |
| ACHCAcadia Healthcare Company, Inc. | COM | 141,189 | $11.6M | 0.4% | 00.0% | Unchanged | History |
| RLYBRallybio Corp | COM | 1,727,067 | $11.3M | 0.4% | −13,864−0.8% | Reduced | History |
| ALGNAlign Technology Inc | COM | 50,824 | $10.7M | 0.4% | +31,930+169.0% | Added | History |
| KRTXKaruna Therapeutics, Inc. | COM | 53,452 | $10.5M | 0.4% | +29,836+126.3% | Added | History |
| LHLabcorp Holdings Inc. | COM NEW | 44,142 | $10.4M | 0.4% | 00.0% | Unchanged | History |
| AVTRAvantor, Inc. | COM | 459,488 | $9.69M | 0.4% | +459,488 | New | History |
| ITCIIntra-Cellular Therapies, Inc. | COM | 172,371 | $9.12M | 0.3% | 00.0% | Unchanged | History |
| TVTXTravere Therapeutics, Inc. | COM | 418,520 | $8.80M | 0.3% | +170,842+69.0% | Added | History |
| CVSCVS Health Corp | Stock | 93,621 | $8.72M | 0.3% | −30,182−24.4% | Reduced | History |
| OHIOmega Healthcare Investors Inc | COM | 306,433 | $8.56M | 0.3% | 00.0% | Unchanged | History |
| ALKSAlkermes plc. | SHS | 309,613 | $8.09M | 0.3% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 672,705 | $7.72M | 0.3% | +323,135+92.4% | Added | History |
| DNLIDenali Therapeutics Inc. | COM | 272,520 | $7.58M | 0.3% | +50,100+22.5% | Added | History |
| MDRXVeradigm Inc. | COM | 428,580 | $7.56M | 0.3% | 00.0% | Unchanged | History |
| ELVElevance Health, Inc. | Stock | 14,644 | $7.51M | 0.3% | 00.0% | Unchanged | History |
| HQYHealthequity, Inc. | COM | 110,214 | $6.79M | 0.3% | 00.0% | Unchanged | History |
| LTCLTC Properties Inc | REIT | 182,293 | $6.48M | 0.2% | 00.0% | Unchanged | History |
| AAgilent Technologies, Inc. | COM | 43,191 | $6.46M | 0.2% | 00.0% | Unchanged | History |
| Vectivbio Hldg AGH9060V101 | ORD SHS | 737,704 | $6.35M | 0.2% | −18,798−2.5% | Reduced | – |
| SBRASabra Health Care REIT, Inc. | REIT | 510,660 | $6.35M | 0.2% | 00.0% | Unchanged | History |
| SNYSanofi | SPONSORED ADR | 123,454 | $5.98M | 0.2% | 00.0% | Unchanged | History |
| CTLTCatalent, Inc. | COM | 125,947 | $5.67M | 0.2% | +125,947 | New | History |
| CERECerevel Therapeutics Holdings, Inc. | COM | 176,483 | $5.57M | 0.2% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 154,269 | $5.38M | 0.2% | 00.0% | Unchanged | History |
| XNCRXencor Inc | COM | 200,328 | $5.22M | 0.2% | 00.0% | Unchanged | History |
| SNNSmith & Nephew PLC | SPDN ADR NEW | 181,710 | $4.89M | 0.2% | 00.0% | Unchanged | History |
| ONCBeOne Medicines Ltd. | ADR | 20,952 | $4.61M | 0.2% | 00.0% | Unchanged | History |
| MPTMedical Properties Trust Inc | COM | 411,743 | $4.59M | 0.2% | 00.0% | Unchanged | History |
| ADUSAddus HomeCare Corp | COM | 42,380 | $4.22M | 0.2% | −41,252−49.3% | Reduced | History |
| RXDXPrometheus Biosciences, Inc. | COM | 38,237 | $4.21M | 0.2% | +6,732+21.4% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 459,651 | $4.19M | 0.2% | 00.0% | Unchanged | History |
| ARWRArrowhead Pharmaceuticals, Inc. | COM | 100,422 | $4.07M | 0.2% | −56,453−36.0% | Reduced | History |
| DOCHealthpeak Properties, Inc. | COM | 150,392 | $3.77M | 0.1% | 00.0% | Unchanged | History |
| CRBUCaribou Biosciences, Inc. | COM | 567,147 | $3.56M | 0.1% | 00.0% | Unchanged | History |
| KURAKura Oncology, Inc. | COM | 283,281 | $3.52M | 0.1% | +283,281 | New | History |
| CYTKCytokinetics Inc | COM NEW | 75,139 | $3.44M | 0.1% | 00.0% | Unchanged | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 66,426 | $3.43M | 0.1% | −199,650−75.0% | Reduced | History |
| CORCencora, Inc. | Stock | 20,417 | $3.38M | 0.1% | +20,417 | New | History |
| HRHealthcare Realty Trust Inc | CL A COM | 174,686 | $3.37M | 0.1% | 00.0% | Unchanged | History |
| IONSIonis Pharmaceuticals Inc | COM | 87,840 | $3.32M | 0.1% | 00.0% | Unchanged | History |
| XENEXenon Pharmaceuticals Inc. | COM | 83,714 | $3.30M | 0.1% | +21,981+35.6% | Added | History |
| ADPTAdaptive Biotechnologies Corp | COM | 422,281 | $3.23M | 0.1% | 00.0% | Unchanged | History |
| iShares Tr464287556 | ISHARES BIOTECH | 24,569 | $3.23M | 0.1% | 00.0% | Unchanged | – |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 300,000 | $3.15M | 0.1% | 00.0% | Unchanged | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 67,065 | $3.11M | 0.1% | 00.0% | Unchanged | History |
| STESTERIS plc | SHS USD | 16,669 | $3.08M | 0.1% | 00.0% | Unchanged | History |
| VTRVentas, Inc. | REIT | 66,681 | $3.00M | 0.1% | 00.0% | Unchanged | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 117,717 | $3.00M | 0.1% | +117,717 | New | History |
Sold out since Q3 2022 (9)
Positions held at the end of Q3 2022 that are gone from this filing.
| Security | Class | Shares in Q3 2022 | Value in Q3 2022 | % of portfolio in Q3 2022 | History |
|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 70,176 | $10.6M | 0.4% | History |
| ACHAccendra Health Inc | Stock | 225,117 | $5.42M | 0.2% | History |
| DSGNDesign Therapeutics, Inc. | COM | 280,523 | $4.69M | 0.2% | History |
| ChemoCentryx, Inc.16383L106 | COM | 78,197 | $4.04M | 0.2% | – |
| State Street Health Care Select Sector SPDR ETF81369Y209 | ETF | 29,024 | $3.52M | 0.1% | – |
| Avidity Biosciences, Inc.05370A108 | COM | 64,618 | $1.05M | <0.1% | – |
| PTGXProtagonist Therapeutics, Inc | COMMON STOCK | 122,271 | $1.03M | <0.1% | History |
| Terumo Corp.688507070 | Common | 17,288 | $487.0K | <0.1% | – |
| ENDPEndo International plc | SHS | 494,607 | $48.0K | <0.1% | History |